Reduced prolyl hydroxylase 3, which inhibits fatty acid oxidation (German et al., 2016), and increased fatty acid-binding protein 4 (Shafat et al., 2017) allow AML cells utilize fatty acids as substrates for OXPHOS. The gene discussed is FABP4; the disease is acute myeloid leukemia.